Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

373 trials

NCT04278339
Recruiting
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder
Not applicable · France · 1 site
Registry update: 24 Mar 2025
NCT03911726
Recruiting
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Not applicable · Germany · 1 site
Registry update: 8 Sept 2026
NCT04414215
Recruiting
Cognitive Training for Emotion Regulation in Psychotic Disorders
Not applicable · United States · 1 site
Registry update: 5 Feb 2025
NCT04610697
Recruiting
Cognitive Remediation in Forensic Mental Health Care
Not applicable · Canada · 1 site
Registry update: 12 Dec 2025
NCT04237155
Recruiting
French Source-monitoring Task
Not applicable · France · 1 site
Registry update: 11 Jun 2026
NCT04267003
Recruiting
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
Not applicable · United States · 1 site
Registry update: 30 Mar 2026
NCT05830903
Recruiting
Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques
Not applicable · Taiwan · 1 site
Registry update: 27 Feb 2026
NCT04159662
Recruiting
Brain Imaging of Cognition Inn Schizophrenia and Depression
Not applicable · Canada · 1 site
Registry update: 23 Mar 2026
NCT05074732
Recruiting
Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
Not applicable · Ireland · 1 site
Registry update: 12 Oct 2021
NCT03601026
Recruiting
Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use
Not applicable · Canada · 1 site
Registry update: 14 May 2025
NCT04113993
Recruiting
Bazedoxifene -Treatment for Women With Schizophrenia
Phase 4 · Australia · 1 site
Registry update: 3 Jun 2026
NCT03971487
Recruiting
Ocrelizumab for Psychosis by Autoimmunity
Phase 1/2 · United States · 1 site
Registry update: 1 Apr 2026
NCT04038840
Recruiting
Imaging Synapses With [11C] UCB-J in the Human Brain
Phase 1 · United States · 2 sites
Registry update: 16 Dec 2024
NCT03817502
Recruiting
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Phase 3 · Bulgaria, Colombia, Mexico, Romania, Serbia, Russia, Ukraine, United States · 56 sites
Registry update: 8 Oct 2025
Conflicting statuses (not updated in the registry for 13 months)
NCT03906435
Recruiting
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
Not applicable · United States · 1 site
Registry update: 9 Jul 2026
NCT03794076
Recruiting
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Phase 1/2 · United States · 1 site
Registry update: 19 Mar 2026
NCT03649581
Recruiting
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
Not applicable · France · 1 site
Registry update: 3 Aug 2025
NCT03495024
Recruiting
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · United States · 1 site
Registry update: 22 Mar 2019
NCT03525054
Recruiting
Semantic and Syntactic Computerized Analysis of Free Speech
Not applicable · France · 3 sites
Registry update: 2 Jun 2026
NCT04745143
Recruiting
Monotherapy of an NMDA Enhancer for Schizophrenia
Phase 2 · Taiwan · 1 site
Registry update: 24 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.